The Roles of TNF Signaling Pathways in Metabolism of Bone Tumors

The metabolism of bone tumors is extraordinarily complex and involves many signaling pathways and processes, including the tumor necrosis factor (TNF) signaling pathway, which consists of TNF factors and the TNF receptors that belong to the TNF receptor superfamily (TNFRSF). It is appreciated that s...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in pharmacology Vol. 13; p. 907629
Main Authors Zhou, Haiying, Dong, Yanzhao, Alhaskawi, Ahmad, Lai, Jingtian, Wang, Zewei, Ezzi, Sohaib Hasan Abdullah, Kota, Vishnu Goutham, Abdulla, Mohamed Hasan Abdulla Hasan, Sun, Zhenyu, Lu, Hui
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 29.06.2022
Subjects
bone tumor
metabolism
Pharmacology
signaling pathways
TNF
TNFRSF
Online AccessGet full text

Cover

More Information
Summary:The metabolism of bone tumors is extraordinarily complex and involves many signaling pathways and processes, including the tumor necrosis factor (TNF) signaling pathway, which consists of TNF factors and the TNF receptors that belong to the TNF receptor superfamily (TNFRSF). It is appreciated that signaling events and pathways involving TNFRSF components are essential in coordinating the functions of multiple cell types that act as a host defense network against pathogens and malignant cells, the implications of TNFRSF-related signaling pathways on bone tumor metabolism remain to be summarized, which is one of the significant obstacles to the application of TNF-related treatment modalities in the domain of bone oncology. This review will discuss and summarize the anti-tumor properties of important TNFRSF components concerning osteosarcoma, chondrosarcoma, and Ewing sarcoma.
Bibliography:content type line 23
SourceType-Scholarly Journals-1
Reviewed by: Tongwei Chu, Third Military Medical University, China
Dirk Geerts, University of Amsterdam, Netherlands
These authors have contributed equally to this work
Edited by: Tianmin Fu, The Ohio State University, United States
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2022.907629